Adjuvant PD-1 inhibitors improve recurrence and survival outcomes in high-risk hepatocellular carcinoma patients after curative hepatectomy
Abstract Background Hepatocellular carcinoma (HCC) is the most prevalent malignancy in China, with liver resection recognized as the primary curative intervention. However, HCC patients face an elevated risk of recurrence, thereby significantly impacting prognosis. Purpose This study aimed to assess...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2025-03-01
|
| Serier: | European Journal of Medical Research |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s40001-025-02444-3 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
